Biodefense Market - Global Forecast To 2030
商品番号 : SMB-79828
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年6月 |
| ページ数 | 218 |
| 図表数 | 252 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
本調査は、バイオディフェンス市場を様々なセグメントおよびサブセグメントにわたって網羅しています。製品、用途、技術、地域に基づき、様々なセグメントにおける市場規模と成長の可能性を推定することを目的としています。また、主要プレーヤーの詳細な競合分析に加え、企業概要、ソリューションおよび事業提供に関する主要な考察、各プレーヤーによる最近の開発状況、主要な市場戦略についても分析しています。
本レポートは、バイオディフェンス市場を北米、欧州、アジア太平洋、その他の5つの主要地域とそれぞれの主要国に分類しています。レポートでは、バイオディフェンス市場の成長に影響を与える推進要因、制約要因、課題、機会といった重要な要素に関する詳細な情報も提供しています。 主要プレーヤーの事業概要、ソリューション、サービスに関する洞察を提供するために、主要な業界プレーヤーを包括的に分析しました。さらに、バイオディフェンス市場に関連する契約、提携、製品発売、契約、事業拡大、買収、パートナーシップといった重要な側面も分析しています。
The biodefense market is estimated at USD 0.89 billion in 2025 and is projected to reach USD 1.81 billion by 2030 at a CAGR of 15.1% during the forecast period. Technological advancements and changing market conditions are the key drivers of the biodefense market.
バイオディフェンス市場は2025年に8億9,000万米ドルに達すると推定され、予測期間中に年平均成長率15.1%で成長し、2030年には18億1,000万米ドルに達すると予測されています。技術の進歩と市場環境の変化が、バイオディフェンス市場の主要な推進力となっています。
“Based on product, sterilization devices under decontamination is estimated to hold the largest market share in 2025.”
Based on product, decontamination is categorized into disinfection units and sterilization devices. Sterilization devices are expected to account for the largest market share in 2025 due to their indispensable function in eliminating a broad biological agent in healthcare, defense, and laboratory environments. The growing need for low-temperature sterilizers, hydrogen peroxide vapor systems, microwave sterilizer units, and gamma irradiation solutions has increased the need for organizations to find stable, validated procedures for decontaminating medical equipment, laboratory surfaces, and delicate equipment. These instruments provide high performance, regulatory approval, and compatibility with intricate and heat-sensitive materials, which are critical to biosafety regulations in hospitals, research facilities, and mobile bio-containment units.
“Biosensor-based technologies segment is estimated to hold the largest market share in 2025 by technology.”
Based on technology, biosensor-based technologies are estimated to account for the largest market in the biodefense market by 2025 due to their pivotal function in providing real-time, precise, and decentralized sensing of biological threats. Biosensor-based technologies are being widely used in hospitals, defense forces, border control, and public health organizations for their high sensitivity and quick response to detecting pathogens like anthrax, ricin, and new viruses. The emergence of point-of-care diagnostics and increasing demand for early warning systems in biodefense applications have considerably enhanced the usage of biosensor technologies. Their versatility in varied environments, ranging from military field operations to urban hospitals and mobile laboratories, makes them valuable to the biodefense market.
“Europe is estimated to hold the second-largest market share in 2025.”
Europe is estimated to have the second-largest share of the biodefense market due to growing government efforts to enhance biosecurity and pandemic preparedness. The region has witnessed increased investment in biosurveillance infrastructure and decontamination technologies. Countries such as Germany, France, and the UK are at the forefront with strong public health systems and country-level biodefense strategies.
Besides that, robust partnerships among defense agencies, biotech firms, and research organizations have boosted innovation in technologies like mobile biocontainment units, biosensors, and AI-based threat detection. Support from EU-wide initiatives such as Horizon Europe and cooperation with the European Centre for Disease Prevention and Control (ECDC) further boost regional readiness.
The break-up of the profile of primary participants in the biodefense market:
- By Company Type: Tier 1 – 35%, Tier 2 – 54%, and Tier 3 – 20%
- By Designation: Directors– 55%, Managers – 27%, Others – 18%
- By Region: North America – 40%, Europe – 20%, Asia Pacific – 30%, Rest of the World – 10%
STERIS (US), ASP International GmbH (US), Ushio Inc. (Japan), Sotera Health Company (US), and Bioquell, An Ecolab Solution (UK) are the key market players that offer connectivity applicable to various sectors and have well-equipped and strong distribution networks across North America, Europe, Asia Pacific, and the Rest of the World.
Research Coverage:
The study covers the biodefense market across various segments and subsegments. It aims to estimate the size and growth potential of this market across different segments based on product, application, technology, and region. This study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their solutions and business offerings, recent developments undertaken by them, and key market strategies adopted by them.
This report segments the biodefense market across five key regions: North America, Europe, Asia Pacific, and the Rest of the World and their respective key countries. The report’s scope includes in-depth information on significant factors, such as drivers, restraints, challenges, and opportunities that influence the growth of the biodefense market.
A comprehensive analysis of major industry players has been conducted to provide insights into their business profiles, solutions, and services. This analysis also covers key aspects like agreements, collaborations, product launches, contracts, expansions, acquisitions, and partnerships associated with the biodefense market.
Reasons to buy this report:
This report serves as a valuable resource for market leaders and newcomers in the biodefense market, offering data that closely approximates revenue figures for both the overall market and its subsegments. It equips stakeholders with a comprehensive understanding of the competitive landscape, facilitating informed decisions to enhance their market positioning and formulating effective go-to-market strategies. The report imparts valuable insights into the market dynamics, offering information on crucial factors such as drivers, restraints, challenges, and opportunities, enabling stakeholders to gauge the market’s pulse.
The report provides insights into the following pointers:
- Analysis of Key Drivers: Rising threat of bioterrorism, high government funding, strategic national stockpiling, and increasing technological advancements
- Market Penetration: Comprehensive information on biodefense solutions offered by the top players in the market
- Product Development/Innovation: Detailed insights into upcoming technologies, research & development activities, and product & service launches in the biodefense market
- Market Development: Comprehensive information about lucrative markets; the report analyses the biodefense market across varied regions
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the biodefense market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players in the biodefense market
Table of Contents
1 INTRODUCTION 22
1.1 STUDY OBJECTIVES 22
1.2 MARKET DEFINITION 22
1.3 MARKET SCOPE 23
1.3.1 BIODEFENSE MARKET SEGMENTATION 23
1.3.2 YEARS CONSIDERED 23
1.4 CURRENCY AND PRICING 24
1.5 INCLUSIONS AND EXCLUSIONS 24
1.6 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH DATA 26
2.1.1 SECONDARY DATA 27
2.1.1.1 Key data from secondary sources 28
2.1.2 PRIMARY DATA 28
2.1.2.1 Key primary sources 28
2.1.2.2 Key data from primary sources 29
2.1.2.3 Breakdown of primary interviews 29
2.2 FACTOR ANALYSIS 30
2.2.1 INTRODUCTION 30
2.2.2 DEMAND-SIDE INDICATORS 30
2.2.3 SUPPLY-SIDE INDICATORS 30
2.3 MARKET SIZE ESTIMATION 31
2.3.1 BOTTOM-UP APPROACH 31
2.3.1.1 Company revenue estimation approach 31
2.3.1.2 Growth rate projections 32
2.3.2 TOP-DOWN APPROACH 32
2.3.2.1 Market assessment by region and country 32
2.4 DATA TRIANGULATION 33
2.5 RESEARCH ASSUMPTIONS 34
2.6 RISK ANALYSIS 34
2.7 RESEARCH LIMITATIONS 34
2.7.1 METHODOLOGY-RELATED LIMITATIONS 34
2.7.2 SCOPE-RELATED LIMITATIONS 34
3 EXECUTIVE SUMMARY 35
4 PREMIUM INSIGHTS 38
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN BIODEFENSE MARKET 38
4.2 BIODEFENSE MARKET, BY PRODUCT 38
4.3 BIODEFENSE MARKET, BY TECHNOLOGY 39
4.4 BIODEFENSE MARKET, BY APPLICATION 39
4.5 BIODEFENSE MARKET, BY COUNTRY 40
5 MARKET OVERVIEW 41
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
5.2.1 DRIVERS 42
5.2.1.1 Rising threat of bioterrorism 42
5.2.1.2 Increase in government funding and strategic national stockpiling 42
5.2.1.3 Technological advancements and innovations 43
5.2.1.4 Growing geopolitical tensions and biological warfare risks 44
5.2.2 RESTRAINTS 45
5.2.2.1 High R&D costs and long approval times 45
5.2.2.2 Lack of global standardization in biodefense protocols 45
5.2.3 OPPORTUNITIES 46
5.2.3.1 Emergence of AI-powered biosurveillance & predictive analytics 46
5.2.3.2 Emergence of nanotechnology-based biosensors 46
5.2.4 CHALLENGES 47
5.2.4.1 Infrastructure shortages in low-resource areas 47
5.2.4.2 Cybersecurity risks in connected biodefense systems 47
5.3 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 48
5.4 VALUE CHAIN ANALYSIS 48
5.4.1 RESEARCH & DEVELOPMENT (~10-20%) 49
5.4.2 RAW MATERIAL PRODUCERS (~20-40%) 49
5.4.3 PRODUCT MANUFACTURING (~40-60%) 49
5.4.4 TESTING & QUALITY ASSURANCE (~60-80%) 49
5.4.5 END USERS (~80-100%) 49
5.5 ECOSYSTEM ANALYSIS 49
5.5.1 PROMINENT COMPANIES 49
5.5.2 PRIVATE AND SMALL ENTERPRISES 49
5.5.3 END USERS 50
5.6 TARIFF AND REGULATORY LANDSCAPE 51
5.7 TRADE DATA 53
5.7.1 IMPORT SCENARIO 53
5.7.2 EXPORT SCENARIO 54
5.8 KEY STAKEHOLDERS AND BUYING CRITERIA 55
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 56
5.8.2 BUYING CRITERIA 56
5.9 USE CASE ANALYSIS 57
5.9.1 USE CASE 1: REAL-TIME PATHOGEN DETECTION AT TORONTO PEARSON INTERNATIONAL AIRPORT 58
5.9.2 USE CASE 2: US–UK STRATEGIC DIALOGUE ON BIOLOGICAL SECURITY 58
5.9.3 USE CASE 3: ENHANCED REMOTE DETECTION OF AEROSOL AND VAPOR THREATS WITH MX908 BEACON 58
5.10 KEY CONFERENCES AND EVENTS, 2025–2026 59
5.11 PRICING ANALYSIS 59
5.11.1 AVERAGE SELLING PRICE OF BIODEFENSE PRODUCTS, BY REGION 60
5.11.2 FACTORS IMPACTING COST IN BIODEFENSE MARKET 60
5.11.3 INDICATIVE PRICING ANALYSIS OF BIODEFENSE TECHNOLOGIES, BY KEY PLAYERS, 2025 63
5.12 INVESTMENT AND FUNDING SCENARIO 63
5.13 IMPACT OF AI/ GENERATIVE AI ON BIODEFENSE MARKET 64
5.13.1 PREDICTIVE BIOSURVEILLANCE 65
5.13.2 NEXT-GENERATION BIOSENSORS 65
5.13.3 RAPID PATHOGEN IDENTIFICATION 65
5.13.4 IMAGE & SIGNAL ANALYSIS 65
5.13.5 SYNTHETIC DATA GENERATION 65
5.14 MACROECONOMIC OUTLOOK 65
5.14.1 INTRODUCTION 65
5.14.2 NORTH AMERICA 66
5.14.3 EUROPE 66
5.14.4 ASIA PACIFIC 66
5.14.5 MIDDLE EAST 66
5.14.6 LATIN AMERICA 67
5.14.7 AFRICA 67
5.15 BUSINESS MODELS 67
5.15.1 BUSINESS MODELS IN BIODEFENSE MARKET 67
5.16 TECHNOLOGY ROADMAP 68
6 INDUSTRY TRENDS 70
6.1 INTRODUCTION 70
6.2 TECHNOLOGY TRENDS 70
6.2.1 NANOTECHNOLOGY-ENABLED BIOSENSORS 70
6.2.2 DIGITAL HEALTH TOOLS & MOBILE BIOSURVEILLANCE 71
6.2.3 REMOTE SENSING FOR DETECTION AND IDENTIFICATION OF BIOLOGICAL THREATS 71
6.2.4 DIGITAL TWINS & SIMULATION TECHNOLOGY 72
6.3 IMPACT OF MEGATRENDS 72
6.3.1 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING FOR BIOTHREAT DETECTION 72
6.3.2 BLOCKCHAIN FOR SUPPLY CHAIN AND DATA INTEGRITY 73
6.4 TECHNOLOGY ANALYSIS 73
6.4.1 KEY TECHNOLOGIES 73
6.4.1.1 Real-time aerosol detectors 73
6.4.1.2 Mass spectrometry 73
6.4.2 COMPLEMENTARY TECHNOLOGIES 74
6.4.2.1 Decision support systems 74
6.4.2.2 Geospatial information systems 74
6.4.3 ADJACENT TECHNOLOGIES 75
6.4.3.1 High-throughput screening 75
6.4.3.2 Digital identity and biometric authentication 75
6.5 PATENT ANALYSIS 76
7 BIODEFENSE MARKET, BY PRODUCT 79
7.1 INTRODUCTION 80
7.2 DETECTION & SURVEILLANCE 81
7.2.1 INCREASING THREAT OF EMERGING INFECTIOUS DISEASES AND BIOTERRORISM TO DRIVE SEGMENTAL GROWTH 81
7.2.2 BIOSENSOR SYSTEMS 82
7.2.3 AI-BASED PLATFORMS 83
7.3 DECONTAMINATION SYSTEMS 84
7.3.1 RISING GOVERNMENT AND DEFENSE SECTOR INVESTMENTS IN BIOSECURITY INFRASTRUCTURE TO DRIVE SEGMENTAL GROWTH 84
7.3.2 DISINFECTION UNITS 84
7.3.3 STERILIZATION DEVICES 86
7.4 OTHERS 87
7.4.1 PURIFICATION UNITS 88
7.4.2 CONTAINMENT & ISOLATION DEVICES 89
8 BIODEFENSE MARKET, BY TECHNOLOGY 91
8.1 INTRODUCTION 92
8.2 GHZ-BAND WAVE EMISSION FOR AIRBORNE VIRAL INACTIVATION 93
8.2.1 CHEMICAL-FREE AND RAPID DECONTAMINATION FEATURE TO DRIVE GROWTH 93
8.3 UV-BASED TECHNOLOGIES 94
8.3.1 GROWING NEED TO REDUCE SPREAD OF AIRBORNE OR SURFACE-DEPOSITED PATHOGENS IN HIGH-RISK AREAS TO DRIVE GROWTH 94
8.4 MICROWAVE HEATING 95
8.4.1 ABILITY TO QUICKLY DISINFECT CONFINED SPACES OR CRITICAL SURFACES EXPOSED TO AIRBORNE BIOTERROR AGENTS TO DRIVE GROWTH 95
8.5 RADIOFREQUENCY (RF-EMR) HEATING 96
8.5.1 STERILIZATION AND DISINFECTION APPLICATIONS TO DRIVE GROWTH 96
8.6 COLD PLASMA-BASED PATHOGEN INACTIVATION 97
8.6.1 BROAD-SPECTRUM PATHOGEN INACTIVATION TO DRIVE GROWTH 97
8.7 GAMMA RADIATION 98
8.7.1 LONG-RANGE AND HIGH-VOLUME APPLICATION TO DRIVE GROWTH 98
8.8 BIOSENSOR TECHNOLOGIES 99
8.8.1 IMMEDIATE THREAT IDENTIFICATION WITHOUT FULL LABORATORY SUPPORT TO DRIVE GROWTH 99
8.8.1.1 Electrochemical biosensors 99
8.8.1.2 Optical biosensors 99
8.8.1.3 Piezoelectric biosensors 99
8.8.1.4 Thermal biosensors 99
8.8.1.5 Nanomechanical biosensors 100
8.9 AI TECHNOLOGIES 100
8.9.1 ABILITY TO PREDICT OUTBREAKS AND IDENTIFY EMERGING THREATS IN REAL TIME TO DRIVE GROWTH 100
8.9.1.1 Machine learning for outbreak prediction 100
8.9.1.2 AI integration with surveillance networks 101
8.10 OTHERS 101
9 BIODEFENSE MARKET, BY APPLICATION 103
9.1 INTRODUCTION 104
9.2 MILITARY 105
9.2.1 THREAT OF BIOLOGICAL WARFARE TO DRIVE DEMAND 105
9.3 HOMELAND SECURITY 105
9.3.1 INCREASING NEED FOR DETECTION AND EARLY WARNING BIODEFENSE SYSTEMS TO DRIVE DEMAND 105
9.4 PUBLIC INFRASTRUCTURE 106
9.4.1 HIGH NEED FOR SAFEGUARDING CITIZENS AND ENSURING RESILIENCE IN FACE OF BIOLOGICAL RISKS TO DRIVE DEMAND 106
9.5 HOSPITALS & MEDICAL INSTITUTES 106
9.5.1 GROWING NEED FOR HEALTHCARE SYSTEM RESILIENCE TO DRIVE DEMAND 106
9.6 OTHERS 106
10 BIODEFENSE MARKET, BY REGION 107
10.1 INTRODUCTION 108
10.2 NORTH AMERICA 109
10.2.1 PESTLE ANALYSIS 109
10.2.2 US 113
10.2.2.1 Rise in global geopolitical tensions due to concerns about bioterrorism and state-sponsored biological programs to drive market 113
10.2.3 CANADA 114
10.2.3.1 Government’s focus on enhancing public health infrastructure to drive market 114
10.3 ASIA PACIFIC 115
10.3.1 PESTLE ANALYSIS 116
10.3.2 INDIA 120
10.3.2.1 Growing national security concerns considering strained relations with neighboring countries to drive market 120
10.3.3 AUSTRALIA 121
10.3.3.1 Increasing government initiatives and investments to drive market 121
10.3.4 CHINA 122
10.3.4.1 Focus on strengthening biosecurity and strategic biotechnology development to drive market 122
10.3.5 JAPAN 124
10.3.5.1 Heightened awareness of biological threats to drive market 124
10.3.6 REST OF ASIA PACIFIC 125
10.4 EUROPE 126
10.4.1 PESTLE ANALYSIS 126
10.4.2 GERMANY 131
10.4.2.1 Comprehensive biosecurity programs and institutional collaboration to drive market 131
10.4.3 UK 132
10.4.3.1 Growing focus on biosurveillance to drive market 132
10.4.4 FRANCE 133
10.4.4.1 Increasing government investment in bioproduction infrastructure and public health preparedness to drive market 133
10.4.5 ITALY 134
10.4.5.1 Increasing focus on building biodefense infrastructure to drive market 134
10.4.6 REST OF EUROPE 136
10.5 REST OF THE WORLD (ROW) 137
10.5.1 PESTLE ANALYSIS 137
10.5.2 MIDDLE EAST & AFRICA 142
10.5.2.1 Increasing need for preparedness for emerging biological threats to drive market 142
10.5.3 LATIN AMERICA 143
10.5.3.1 International collaborations to strengthen national biodefense efforts to drive market 143
11 COMPETITIVE LANDSCAPE 145
11.1 INTRODUCTION 145
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2025 145
11.3 BIODEFENSE MARKET REVENUE ANALYSIS, 2020–2025 146
11.4 BIODEFENSE MARKET SHARE ANALYSIS, 2024 147
11.5 BIODEFENSE MARKET COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 149
11.5.1 STARS 149
11.5.2 EMERGING LEADERS 149
11.5.3 PERVASIVE PLAYERS 149
11.5.4 PARTICIPANTS 150
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 151
11.5.5.1 Company footprint 151
11.5.5.2 Product footprint 151
11.5.5.3 Technology footprint 152
11.5.5.4 Application footprint 153
11.5.5.5 Region footprint 153
11.6 BIODEFENSE MARKET COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 154
11.6.1 PROGRESSIVE COMPANIES 154
11.6.2 RESPONSIVE COMPANIES 154
11.6.3 DYNAMIC COMPANIES 154
11.6.4 STARTING BLOCKS 154
11.6.5 COMPETITIVE BENCHMARKING 156
11.6.5.1 List of startups/SMEs 156
11.6.5.2 Competitive benchmarking of startups/SMEs 157
11.7 BRAND/PRODUCT COMPARISON 158
11.8 COMPANY VALUATION AND FINANCIAL METRICS 159
11.9 COMPETITIVE SCENARIO 160
11.9.1 DEALS 160
11.9.2 OTHER DEVELOPMENTS 163
12 COMPANY PROFILES 164
12.1 KEY PLAYERS 164
12.1.1 STERIS 164
12.1.1.1 Business overview 164
12.1.1.2 Products offered 165
12.1.1.3 Recent developments 166
12.1.1.3.1 Deals 166
12.1.1.4 MnM view 166
12.1.1.4.1 Key strengths 166
12.1.1.4.2 Strategic choices 166
12.1.1.4.3 Weaknesses and competitive threats 166
12.1.2 ASP INTERNATIONAL GMBH 167
12.1.2.1 Business overview 167
12.1.2.2 Products offered 168
12.1.2.3 MnM view 169
12.1.2.3.1 Key strengths 169
12.1.2.3.2 Strategic choices 169
12.1.2.3.3 Weaknesses and competitive threats 169
12.1.3 USHIO INC. 170
12.1.3.1 Business overview 170
12.1.3.2 Products offered 171
12.1.3.3 Recent developments 172
12.1.3.3.1 Deals 172
12.1.3.4 MnM view 172
12.1.3.4.1 Key strengths 172
12.1.3.4.2 Strategic choices 172
12.1.3.4.3 Weaknesses and competitive threats 172
12.1.4 SOTERA HEALTH COMPANY 173
12.1.4.1 Business overview 173
12.1.4.2 Products offered 174
12.1.4.3 MnM view 175
12.1.4.3.1 Key strengths 175
12.1.4.3.2 Strategic choices 175
12.1.4.3.3 Weaknesses and competitive threats 175
12.1.5 BIOQUELL, AN ECOLAB SOLUTION 176
12.1.5.1 Business overview 176
12.1.5.2 Products offered 177
12.1.5.3 MnM view 178
12.1.5.3.1 Key strengths 178
12.1.5.3.2 Strategic choices 178
12.1.5.3.3 Weaknesses and competitive threats 178
12.1.6 THERMO FISHER SCIENTIFIC INC. 179
12.1.6.1 Business overview 179
12.1.6.2 Products offered 180
12.1.6.3 Recent developments 181
12.1.6.3.1 Deals 181
12.1.7 SMITHS DETECTION GROUP LTD 182
12.1.7.1 Business overview 182
12.1.7.2 Products offered 182
12.1.7.3 Recent developments 183
12.1.7.3.1 Deals 183
12.1.8 E4LIFE SRL. 184
12.1.8.1 Business overview 184
12.1.8.2 Products offered 184
12.1.9 SYNEXIS 185
12.1.9.1 Business overview 185
12.1.9.2 Products offered 185
12.1.9.3 Recent developments 186
12.1.9.3.1 Deals 186
12.1.10 BLUEDOT INC. 187
12.1.10.1 Business overview 187
12.1.10.2 Products offered 187
12.1.10.3 Recent developments 188
12.1.10.3.1 Deals 188
12.1.11 XENEX DISINFECTION SERVICES INC. 189
12.1.11.1 Business overview 189
12.1.11.2 Products offered 189
12.1.11.3 Recent developments 190
12.1.11.3.1 Other developments 190
12.1.12 SKAN AG 191
12.1.12.1 Business overview 191
12.1.12.2 Products offered 192
12.1.12.3 Recent developments 192
12.1.12.3.1 Deals 192
12.1.13 MICROSOFT 193
12.1.13.1 Business overview 193
12.1.13.2 Products offered 194
12.1.14 BIO-RAD LABORATORIES, INC. 195
12.1.14.1 Business overview 195
12.1.14.2 Products offered 196
12.1.15 AIRBOSS DEFENSE GROUP, INC. 197
12.1.15.1 Business overview 197
12.1.15.2 Products offered 198
12.1.15.3 Recent developments 198
12.1.15.3.1 Deals 198
12.2 OTHER PLAYERS 199
12.2.1 IONISOS 199
12.2.2 AQUISENSE 199
12.2.3 GERMFREE 200
12.2.4 PATHOGENFOCUS 201
12.2.5 UV LIGHT TECHNOLOGY LTD – PART OF DARO GROUP 202
12.2.6 BERTIN TECHNOLOGIES 203
12.2.7 FAR UV TECHNOLOGIES, INC. 203
12.2.8 PURE AQUA, INC. 204
12.2.9 PALANTIR TECHNOLOGIES INC. 205
12.2.10 PÜSCHNER MICROWAVE POWER SYSTEMS 206
13 APPENDIX 207
13.1 DISCUSSION GUIDE 207
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 209
13.3 CUSTOMIZATION OPTIONS 211
13.4 RELATED REPORTS 211
13.5 COMPANY LONG LIST 213
13.6 AUTHOR DETAILS 217
LIST OF TABLES
TABLE 1 USD EXCHANGE RATES, 2019–2024 24
TABLE 2 BIODEFENSE MARKET: INCLUSIONS AND EXCLUSIONS 24
TABLE 3 IMPACT OF TECHNOLOGICAL ADVANCEMENTS ON BIODEFENSE MARKET: COMPARISON OF TRADITIONAL VS. MODERN APPROACHES 43
TABLE 4 ROLE OF COMPANIES IN ECOSYSTEM 50
TABLE 5 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 51
TABLE 6 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 52
TABLE 7 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 52
TABLE 8 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 53
TABLE 9 IMPORT DATA FOR HS CODE 901890, BY COUNTRY,
2020–2024 (USD THOUSAND) 54
TABLE 10 EXPORT DATA FOR HS CODE 901890, BY COUNTRY,
2020–2024 (USD THOUSAND) 55
TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TOP 3 APPLICATIONS (%) 56
TABLE 12 KEY BUYING CRITERIA, BY TOP 3 APPLICATIONS 57
TABLE 13 KEY CONFERENCES AND EVENTS, 2025–2026 59
TABLE 14 AVERAGE SELLING PRICE OF BIODEFENSE PRODUCTS, BY REGION, 2024 (USD) 60
TABLE 15 INDICATIVE PRICING OF BIODEFENSE TECHNOLOGIES, BY KEY PLAYERS, 2025 63
TABLE 16 COMPARISON BETWEEN DIFFERENT BUSINESS MODELS 68
TABLE 17 LIST OF MAJOR PATENTS FOR BIODEFENSE, 2023–2025 77
TABLE 18 BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 80
TABLE 19 BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 81
TABLE 20 BIODEFENSE MARKET FOR DETECTION & SURVEILLANCE PRODUCT TYPES,
2021–2024 (USD MILLION) 81
TABLE 21 BIODEFENSE MARKET FOR DETECTION & SURVEILLANCE PRODUCT TYPES,
2025–2030 (USD MILLION) 81
TABLE 22 DETECTION & SURVEILLANCE: BIODEFENSE MARKET, BY BIOSENSOR PRODUCT TYPE, 2021–2024 (USD MILLION) 82
TABLE 23 DETECTION & SURVEILLANCE: BIODEFENSE MARKET, BY BIOSENSOR PRODUCT TYPE, 2025–2030 (USD MILLION) 82
TABLE 24 SMITH DETECTION GROUP LTD: BIOFLASH BIOLOGICAL IDENTIFIER: SPECIFICATIONS 82
TABLE 25 DETECTION & SURVEILLANCE: BIODEFENSE MARKET, BY AI-BASED PLATFORM TYPE, 2021–2024 (USD MILLION) 83
TABLE 26 DETECTION & SURVEILLANCE: BIODEFENSE MARKET, BY AI-BASED PLATFORM TYPE, 2025–2030 (USD MILLION) 83
TABLE 27 KRAKEN SENSE PRODUCT: KRAKEN™ PATHOGEN RISK DETECTION SYSTEM: SPECIFICATIONS 83
TABLE 28 BIODEFENSE MARKET, BY DECONTAMINATION SYSTEM TYPE,
2021–2024 (USD MILLION) 84
TABLE 29 BIODEFENSE MARKET, BY DECONTAMINATION SYSTEM TYPE,
2025–2030 (USD MILLION) 84
TABLE 30 BIODEFENSE DISINFECTION UNITS MARKET, BY TECHNOLOGY,
2021–2024 (USD MILLION) 85
TABLE 31 BIODEFENSE DISINFECTION UNITS MARKET, BY TECHNOLOGY,
2025–2030 (USD MILLION) 85
TABLE 32 DRDO PRODUCT: UV BLASTER–AREA UV DISINFECTION SYSTEM: SPECIFICATIONS 85
TABLE 33 BIODEFENSE STERILIZATION DEVICES MARKET, BY TECHNOLOGY,
2021–2024 (USD MILLION) 86
TABLE 34 BIODEFENSE STERILIZATION DEVICES MARKET, BY TECHNOLOGY,
2025–2030 (USD MILLION) 86
TABLE 35 STERIS PLC PRODUCT: STERIS VHP M100 BIODECONTAMINATION UNIT: SPECIFICATIONS 87
TABLE 36 BIODEFENSE MARKET, BY OTHER PRODUCTS, 2021–2024 (USD MILLION) 87
TABLE 37 BIODEFENSE MARKET, BY OTHER PRODUCTS, 2025–2030 (USD MILLION) 87
TABLE 38 BIODEFENSE PURIFICATION UNITS MARKET, BY TECHNOLOGY,
2021–2024 (USD MILLION) 88
TABLE 39 BIODEFENSE PURIFICATION UNITS MARKET, BY TECHNOLOGY,
2025–2030 (USD MILLION) 88
TABLE 40 CASTELLEX PRODUCT: AIR 40 BIO FILTRATION UNIT WITH UV LIGHT: SPECIFICATIONS 89
TABLE 41 BIODEFENSE CONTAINMENT & ISOLATION DEVICES MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 90
TABLE 42 BIODEFENSE CONTAINMENT & ISOLATION DEVICES MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 90
TABLE 43 EPIGUARD PRODUCT: EPISHUTTLE–MEDICAL ISOLATION AND TRANSPORT UNIT: SPECIFICATIONS 90
TABLE 44 BIODEFENSE MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 92
TABLE 45 BIODEFENSE MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 93
TABLE 46 BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 104
TABLE 47 BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 105
TABLE 48 BIODEFENSE MARKET, BY REGION, 2021–2024 (USD MILLION) 108
TABLE 49 BIODEFENSE MARKET, BY REGION, 2025–2030 (USD MILLION) 109
TABLE 50 NORTH AMERICA: BIODEFENSE MARKET, BY COUNTRY,
2021–2024 (USD MILLION) 111
TABLE 51 NORTH AMERICA: BIODEFENSE MARKET, BY COUNTRY,
2025–2030 (USD MILLION) 111
TABLE 52 NORTH AMERICA: BIODEFENSE MARKET, BY PRODUCT,
2021–2024 (USD MILLION) 111
TABLE 53 NORTH AMERICA: BIODEFENSE MARKET, BY PRODUCT,
2025–2030 (USD MILLION) 111
TABLE 54 NORTH AMERICA: BIODEFENSE MARKET, BY TECHNOLOGY,
2021–2024 (USD MILLION) 112
TABLE 55 NORTH AMERICA: BIODEFENSE MARKET, BY TECHNOLOGY,
2025–2030 (USD MILLION) 112
TABLE 56 NORTH AMERICA: BIODEFENSE MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 112
TABLE 57 NORTH AMERICA: BIODEFENSE MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 113
TABLE 58 US: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 113
TABLE 59 US: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 113
TABLE 60 US: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 114
TABLE 61 US: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 114
TABLE 62 CANADA: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 114
TABLE 63 CANADA: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 115
TABLE 64 CANADA: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 115
TABLE 65 CANADA: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 115
TABLE 66 ASIA PACIFIC: BIODEFENSE MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 118
TABLE 67 ASIA PACIFIC: BIODEFENSE MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 118
TABLE 68 ASIA PACIFIC: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 118
TABLE 69 ASIA PACIFIC: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 118
TABLE 70 ASIA PACIFIC: BIODEFENSE MARKET, BY TECHNOLOGY,
2021–2024 (USD MILLION) 119
TABLE 71 ASIA PACIFIC: BIODEFENSE MARKET, BY TECHNOLOGY,
2025–2030 (USD MILLION) 119
TABLE 72 ASIA PACIFIC: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 119
TABLE 73 ASIA PACIFIC: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 120
TABLE 74 INDIA: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 120
TABLE 75 INDIA: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 120
TABLE 76 INDIA: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 121
TABLE 77 INDIA: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 121
TABLE 78 AUSTRALIA: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 121
TABLE 79 AUSTRALIA: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 122
TABLE 80 AUSTRALIA: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 122
TABLE 81 AUSTRALIA: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 122
TABLE 82 CHINA: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 123
TABLE 83 CHINA: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 123
TABLE 84 CHINA: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 123
TABLE 85 CHINA: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 123
TABLE 86 JAPAN: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 124
TABLE 87 JAPAN: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 124
TABLE 88 JAPAN: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 124
TABLE 89 JAPAN: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 125
TABLE 90 REST OF ASIA PACIFIC: BIODEFENSE MARKET, BY PRODUCT,
2021–2024 (USD MILLION) 125
TABLE 91 REST OF ASIA PACIFIC: BIODEFENSE MARKET, BY PRODUCT,
2025–2030 (USD MILLION) 125
TABLE 92 REST OF ASIA PACIFIC: BIODEFENSE MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 126
TABLE 93 REST OF ASIA PACIFIC: BIODEFENSE MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 126
TABLE 94 EUROPE: BIODEFENSE MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 128
TABLE 95 EUROPE: BIODEFENSE MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 129
TABLE 96 EUROPE: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 129
TABLE 97 EUROPE: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 129
TABLE 98 EUROPE: BIODEFENSE MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 129
TABLE 99 EUROPE: BIODEFENSE MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 130
TABLE 100 EUROPE: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 130
TABLE 101 EUROPE: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 130
TABLE 102 GERMANY: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 131
TABLE 103 GERMANY: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 131
TABLE 104 GERMANY: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 131
TABLE 105 GERMANY: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 132
TABLE 106 UK: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 132
TABLE 107 UK: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 132
TABLE 108 UK: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 133
TABLE 109 UK: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 133
TABLE 110 FRANCE: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 133
TABLE 111 FRANCE: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 134
TABLE 112 FRANCE: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 134
TABLE 113 FRANCE: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 134
TABLE 114 ITALY: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 135
TABLE 115 ITALY: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 135
TABLE 116 ITALY: BIODEFENSE MARKET, BY APPLICATION, 2021–2024 (USD MILLION) 135
TABLE 117 ITALY: BIODEFENSE MARKET, BY APPLICATION, 2025–2030 (USD MILLION) 135
TABLE 118 REST OF EUROPE: BIODEFENSE MARKET, BY PRODUCT,
2021–2024 (USD MILLION) 136
TABLE 119 REST OF EUROPE: BIODEFENSE MARKET, BY PRODUCT,
2025–2030 (USD MILLION) 136
TABLE 120 REST OF EUROPE: BIODEFENSE MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 136
TABLE 121 REST OF EUROPE: BIODEFENSE MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 137
TABLE 122 REST OF THE WORLD: BIODEFENSE MARKET, BY REGION,
2021–2024 (USD MILLION) 139
TABLE 123 REST OF THE WORLD: BIODEFENSE MARKET, BY REGION,
2025–2030 (USD MILLION) 139
TABLE 124 REST OF THE WORLD: BIODEFENSE MARKET, BY PRODUCT,
2021–2024 (USD MILLION) 140
TABLE 125 REST OF THE WORLD: BIODEFENSE MARKET, BY PRODUCT,
2025–2030 (USD MILLION) 140
TABLE 126 REST OF THE WORLD: BIODEFENSE MARKET, BY TECHNOLOGY,
2021–2024 (USD MILLION) 140
TABLE 127 REST OF THE WORLD: BIODEFENSE MARKET, BY TECHNOLOGY,
2025–2030 (USD MILLION) 141
TABLE 128 REST OF THE WORLD: BIODEFENSE MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 141
TABLE 129 REST OF THE WORLD: BIODEFENSE MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 141
TABLE 130 MIDDLE EAST & AFRICA: BIODEFENSE MARKET, BY PRODUCT,
2021–2024 (USD MILLION) 142
TABLE 131 MIDDLE EAST & AFRICA: BIODEFENSE MARKET, BY PRODUCT,
2025–2030 (USD MILLION) 142
TABLE 132 MIDDLE EAST & AFRICA: BIODEFENSE MARKET, BY APPLICATION,
2021–2024 (USD MILLION 143
TABLE 133 MIDDLE EAST & AFRICA: BIODEFENSE MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 143
TABLE 134 LATIN AMERICA: BIODEFENSE MARKET, BY PRODUCT, 2021–2024 (USD MILLION) 143
TABLE 135 LATIN AMERICA: BIODEFENSE MARKET, BY PRODUCT, 2025–2030 (USD MILLION) 144
TABLE 136 LATIN AMERICA: BIODEFENSE MARKET, BY APPLICATION,
2021–2024 (USD MILLION) 144
TABLE 137 LATIN AMERICA: BIODEFENSE MARKET, BY APPLICATION,
2025–2030 (USD MILLION) 144
TABLE 138 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2025 145
TABLE 139 BIODEFENSE MARKET: DEGREE OF COMPETITION 147
TABLE 140 BIODEFENSE MARKET: PRODUCT FOOTPRINT 151
TABLE 141 BIODEFENSE MARKET: TECHNOLOGY FOOTPRINT 152
TABLE 142 BIODEFENSE MARKET: APPLICATION FOOTPRINT 153
TABLE 143 BIODEFENSE MARKET: REGION FOOTPRINT 153
TABLE 144 BIODEFENSE MARKET: LIST OF STARTUPS/SMES 156
TABLE 145 BIODEFENSE MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 157
TABLE 146 BIODEFENSE MARKET: DEALS, 2020–2025 160
TABLE 147 BIODEFENSE MARKET: OTHER DEVELOPMENTS, 2020–2025 163
TABLE 148 STERIS: COMPANY OVERVIEW 164
TABLE 149 STERIS: PRODUCTS OFFERED 165
TABLE 150 STERIS: DEALS 166
TABLE 151 ASP INTERNATIONAL GMBH: COMPANY OVERVIEW 167
TABLE 152 ASP INTERNATIONAL GMBH: PRODUCTS OFFERED 168
TABLE 153 USHIO INC.: COMPANY OVERVIEW 170
TABLE 154 USHIO INC.: PRODUCTS OFFERED 171
TABLE 155 USHIO INC.: DEALS 172
TABLE 156 SOTERA HEALTH COMPANY: COMPANY OVERVIEW 173
TABLE 157 SOTERA HEALTH COMPANY: PRODUCTS OFFERED 174
TABLE 158 BIOQUELL, AN ECOLAB SOLUTION: COMPANY OVERVIEW 176
TABLE 159 BIOQUELL, AN ECOLAB SOLUTION: PRODUCTS OFFERED 177
TABLE 160 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 179
TABLE 161 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED 180
TABLE 162 THERMO FISHER SCIENTIFIC INC.: DEALS 181
TABLE 163 SMITHS DETECTION GROUP LTD: COMPANY OVERVIEW 182
TABLE 164 SMITHS DETECTION GROUP LTD: PRODUCTS OFFERED 182
TABLE 165 SMITHS DETECTION GROUP LTD: DEALS 183
TABLE 166 E4LIFE SRL.: COMPANY OVERVIEW 184
TABLE 167 E4LIFE SRL.: PRODUCTS OFFERED 184
TABLE 168 SYNEXIS: COMPANY OVERVIEW 185
TABLE 169 SYNEXIS: PRODUCTS OFFERED 185
TABLE 170 SYNEXIS: DEALS 186
TABLE 171 BLUEDOT INC.: COMPANY OVERVIEW 187
TABLE 172 BLUEDOT INC.: PRODUCTS OFFERED 187
TABLE 173 BLUEDOT INC.: DEALS 188
TABLE 174 XENEX DISINFECTION SERVICES INC.: COMPANY OVERVIEW 189
TABLE 175 XENEX DISINFECTION SERVICES INC.: PRODUCTS OFFERED 189
TABLE 176 XENEX DISINFECTION SERVICES INC.: OTHER DEVELOPMENTS 190
TABLE 177 SKAN AG: COMPANY OVERVIEW 191
TABLE 178 SKAN AG: PRODUCTS OFFERED 192
TABLE 179 SKAN AG : DEALS 192
TABLE 180 MICROSOFT: COMPANY OVERVIEW 193
TABLE 181 MICROSOFT: PRODUCTS OFFERED 194
TABLE 182 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 195
TABLE 183 BIO-RAD LABORATORIES, INC.: PRODUCTS OFFERED 196
TABLE 184 AIRBOSS DEFENSE GROUP, INC.: COMPANY OVERVIEW 197
TABLE 185 AIRBOSS DEFENSE GROUP, INC.: PRODUCTS OFFERED 198
TABLE 186 AIRBOSS DEFENSE GROUP, INC.: DEALS 198
TABLE 187 IONISOS: COMPANY OVERVIEW 199
TABLE 188 AQUISENSE: COMPANY OVERVIEW 199
TABLE 189 GERMFREE: COMPANY OVERVIEW 200
TABLE 190 PATHOGENFOCUS: COMPANY OVERVIEW 201
TABLE 191 UV LIGHT TECHNOLOGY LTD – PART OF DARO GROUP: COMPANY OVERVIEW 202
TABLE 192 BERTIN TECHNOLOGIES: COMPANY OVERVIEW 203
TABLE 193 FAR UV TECHNOLOGIES, INC.: COMPANY OVERVIEW 203
TABLE 194 PURE AQUA, INC.: COMPANY OVERVIEW 204
TABLE 195 PALANTIR TECHNOLOGIES INC.: COMPANY OVERVIEW 205
TABLE 196 PÜSCHNER MICROWAVE POWER SYSTEMS: COMPANY OVERVIEW 206
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS FLOW 26
FIGURE 2 BIODEFENSE MARKET: RESEARCH DESIGN 27
FIGURE 3 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 31
FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 32
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 32
FIGURE 6 DATA TRIANGULATION 33
FIGURE 7 DECONTAMINATION SYSTEMS TO BE LEADING PRODUCT SEGMENT OF BIODEFENSE MARKET IN 2030 35
FIGURE 8 AI TECHNOLOGIES TO REGISTER DECENT CAGR DURING FORECAST PERIOD 36
FIGURE 9 HOSPITALS & MEDICAL INSTITUTES TO BE LEADING APPLICATION OF BIODEFENSE IN 2025 36
FIGURE 10 NORTH AMERICA TO ACCOUNT FOR LARGEST SHARE OF BIODEFENSE MARKET
IN 2025 37
FIGURE 11 INCREASING ADVANCEMENTS IN BIODEFENSE TECHNOLOGIES TO DRIVE GROWTH 38
FIGURE 12 DECONTAMINATION SYSTEMS SEGMENT TO LEAD BIODEFENSE MARKET IN 2025 38
FIGURE 13 AI TECHNOLOGIES SEGMENT TO LEAD BIODEFENSE MARKET IN 2025 39
FIGURE 14 HOSPITALS & MEDICAL INSTITUTES SEGMENT TO LEAD BIODEFENSE MARKET
IN 2025 39
FIGURE 15 AUSTRALIA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 40
FIGURE 16 BIODEFENSE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41
FIGURE 17 TRENDS AND DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 48
FIGURE 18 VALUE CHAIN ANALYSIS 48
FIGURE 19 ECOSYSTEM ANALYSIS 50
FIGURE 20 IMPORT DATA FOR HS CODE 901890, BY COUNTRY,
2020–2024 (USD THOUSAND) 54
FIGURE 21 EXPORT DATA FOR HS CODE 901890, 2020–2024 (USD THOUSAND) 55
FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY TOP 3 APPLICATIONS 56
FIGURE 23 KEY BUYING CRITERIA, BY TOP 3 APPLICATIONS 57
FIGURE 24 AVERAGE SELLING PRICE OF BIODEFENSE PRODUCTS, BY REGION 60
FIGURE 25 INVESTMENT AND FUNDING SCENARIO, 2020–2024 64
FIGURE 26 BIODEFENSE MARKET: IMPACT OF AI/GEN AI 64
FIGURE 27 BUSINESS MODELS IN BIODEFENSE MARKET 67
FIGURE 28 EVOLUTION OF TECHNOLOGY IN BIODEFENSE MARKET 68
FIGURE 29 TECHNOLOGY ROADMAP 69
FIGURE 30 LIST OF MAJOR PATENTS RELATED TO BIODEFENSE, 2014–2025 76
FIGURE 31 DECONTAMINATION SYSTEMS SEGMENT TO LEAD BIODEFENSE MARKET DURING FORECAST PERIOD 80
FIGURE 32 AI TECHNOLOGIES SEGMENT TO LEAD BIODEFENSE MARKET IN 2030 92
FIGURE 33 HOSPITALS & MEDICAL INSTITUTES SEGMENT TO LEAD BIODEFENSE MARKET DURING FORECAST PERIOD 104
FIGURE 34 BIODEFENSE MARKET, BY REGION, 2025–2030 108
FIGURE 35 NORTH AMERICA: BIODEFENSE MARKET SNAPSHOT 110
FIGURE 36 ASIA PACIFIC: BIODEFENSE MARKET SNAPSHOT 117
FIGURE 37 EUROPE: BIODEFENSE MARKET SNAPSHOT 128
FIGURE 38 REST OF THE WORLD: BIODEFENSE MARKET SNAPSHOT 139
FIGURE 39 BIODEFENSE MARKET REVENUE ANALYSIS OF TOP 5 PLAYERS,
2021–2024 (USD MILLION) 146
FIGURE 40 BIODEFENSE MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 147
FIGURE 41 BIODEFENSE MARKET COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 150
FIGURE 42 BIODEFENSE MARKET: COMPANY FOOTPRINT 151
FIGURE 43 BIODEFENSE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 155
FIGURE 44 BRAND/PRODUCT COMPARISON 158
FIGURE 45 FINANCIAL METRICS OF PROMINENT MARKET PLAYERS 159
FIGURE 46 VALUATION OF PROMINENT MARKET PLAYERS 159
FIGURE 47 STERIS: COMPANY SNAPSHOT 165
FIGURE 48 ASP INTERNATIONAL GMBH: COMPANY SNAPSHOT 168
FIGURE 49 USHIO INC.: COMPANY SNAPSHOT 171
FIGURE 50 SOTERA HEALTH COMPANY: COMPANY SNAPSHOT 174
FIGURE 51 BIOQUELL, AN ECOLAB SOLUTION: COMPANY SNAPSHOT 177
FIGURE 52 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT 180
FIGURE 53 SKAN AG: COMPANY SNAPSHOT 191
FIGURE 54 MICROSOFT: COMPANY SNAPSHOT 194
FIGURE 55 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT 196
FIGURE 56 AIRBOSS DEFENSE GROUP, INC.: COMPANY SNAPSHOT 197
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | USD9,150 | USD9,650 | USD11,500 |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 軟組織修復市場 – 2030年までの世界予測 2025-07-02
- エポキシ樹脂市場 – 2030年までの世界予測 2025-07-02
- スマートガスメーター市場 – 2030年までの世界予測 2025-07-02
- サイバーセキュリティ市場 – 2030年までの世界予測 2025-07-02
- パイプ用断熱材市場 – 2030年までの世界予測 2025-07-01